Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00362778Phase 4Completed
Phase 4, randomised, open-label trial of human insulin in hyperglycemia (2 arms), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Glycemic control at 48 hours. Started Jan 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00362778.